Processa Pharmaceuticals (PCSA) stock

Worth $5.2MShares as of Aug 7

$1.87

-4.10%

As of Tuesday's close · Live for Pro members at the open

Not scored

Breakaway doesn't score PCSA. It is too small and too thinly traded for a fair Quality Score.

Healthcare · Biotech

Next2H 2026“We intend to initiate this trial in the second half of 2026…”Trial start · SEC filing · Oct 5

Follow PCSA's news. Pro members can get an alert when Processa Pharmaceuticals files news, and see its trials, share raises, and its CEO's filings.

Get an alert when PCSA files newsSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. 3,168 stocks are scored and ranked, every 15 seconds while the market is open. Pro members see it live.

What's next for PCSA, and how long its cash lasts

Next step the company has named

2H 2026“We intend to initiate this trial in the second half of 2026 and expect to report proof of concept data in the second half of 2027.”Trial start · SEC filing · Oct 5

What it means: when a trial begins, or reaches the stage the company named.

For Pro members: 3 more milestones and 49 filings.

Cash runway

The company says its cash lasts into the second half of 2029 (8-K, Nov 5).

That is the company's estimate. Our arithmetic on its latest balance sheet reads differently, so we show its words, not ours.

For Pro members: the cash on hand, the cash used each quarter, and the math.

Dilution on the horizon

Shelf registration (S-3, filed May 21, 2024)
At-the-market share sales program (424B5, filed May 28, 2024)

For Pro members: 4 raises and their amounts, and the share count against a year ago.

Insiders

CEO George K Ng bought 3,057 shares on Jul 1. 41 more insider trades this year.

From Form 4: open-market buys and sales only.

Get an alert when George Ng buys or sells

For Pro members: every trade, and George Ng’s 18 filings and quotes.

Get an alert when PCSA files newsA free account. No card.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 12 daysFDA decisionIn 12 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $500MDeramiocelFDA decision due (PDUFA)
In 12 daysFDA decisionIn 12 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $900MMolgramostimFDA decision due (PDUFA)
In 42 daysFDA decisionIn 42 days · FDA decisionMLYSMineralys TherapeuticsLorundrostatMLYSMineralys Therapeutics · $1.3BLorundrostatFDA decision due (PDUFA)

14 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 151 dates, ranked →

PCSA's latest filings

Other news8-K, filed Nov 5
Shelf registration, to sell securities laterS-3, filed Oct 9
Quarterly report10-Q, filed Aug 14

23 more filings in the last year, for Pro members

From SEC EDGAR, as filed. Each opens the filing on the SEC's site.

Why PCSA isn't scored

The Quality Score reads US-listed stocks worth $50M or more that trade at $1 or more and 300,000 shares or $10M a day. PCSA is worth about $5.2M and trades about 50,000 shares a day. A stock that clears every mark is scored from the next weekly rebuild.

Straight AnswersStraight Answers

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.